PITTSBURGH, March 15 /PRNewswire/ -- CardiacAssist, Inc., a Pittsburgh- based medical device company that develops, manufactures and markets cardiac assist devices, is exhibiting the TandemHeart(R) PTVA(R) System at the 56th Annual American College of Cardiology (ACC) Scientific Session in New Orleans. The TandemHeart System provides extracorporeal circulatory support through a percutaneous cardiac catheterization procedure in as little as 30 minutes.
ACC 2007 will be held in the Ernest Morial Convention Center March 24 - 27, 2007. The scientific session will include the second annual Innovation in Intervention: i2 Summit, which is geared to interventional cardiology. CardiacAssist will be in booth number 3544 with information and displays pertaining to its TandemHeart System.
Additionally, CardiacAssist will hold an evening meeting on Sunday, March 25 from 5:30 p.m.- 8:00 p.m. at the nearby Hilton Garden Inn. The meeting will feature key TandemHeart System users from Lenox Hill Hospital, Texas Heart Institute, Cleveland Clinic and the University of Michigan.
Current and prospective customers are encouraged to attend to learn more about use of the TandemHeart System. ACC/i2 Summit attendees interested in this meeting should visit CardiacAssist's booth to receive an invitation, or contact Monica Bush at 412-963-7770 ext. 247 or mbush@cardiacassist.com.
"We're very excited to demonstrate the improvements and extensive clinical experience of the TandemHeart System at the world's most prestigious cardiovascular scientific meeting," said CardiacAssist CEO Michael Garippa.
CardiacAssist recently surpassed its 850th successful TandemHeart System procedure, and the recently introduced Escort Controller component is now available. The Escort Controller is one of three primary components of the TandemHeart PTVA System. Weighing only 21 pounds, it can be mounted at bedside, on an IV pole or on a table top. It is intended primarily for AC power use, but has enough battery back-up power for an hour of operation.
The TandemHeart System is designed to be used as an extracorporeal circulatory support system for procedures not requiring complete cardiopulmonary bypass. The device has received FDA 510(k) clearance for use for up to six hours and is the only FDA approved device of its kind in the U.S.
The TandemHeart System is fully reimbursed by Medicare under existing DRG codes. The device can be placed rapidly in the cath lab or operating room, providing effective, reliable, temporary circulatory support. To date, the TandemHeart System has been used in 28 countries at 100 different facilities by 140 different physicians.
About CardiacAssist
Founded in 1996, CardiacAssist, Inc. is a privately held, Pittsburgh-based medical device company that develops, manufactures and markets innovative products designed to provide cardiologists and cardiac surgeons with minimally invasive solutions for providing extracorporeal circulatory support. Its vision is to help advance the treatment of heart disease by bridging gaps in current treatment methodologies.
This press release may contain certain forward-looking statements that relate to CardiacAssist's future business and financial performance. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein.
Media Contact: Jennifer Hanson Armada Medical Marketing 303-623-1190 x239 jenniferh@armadamedical.com Monica Bush CardiacAssist, Inc. 412-963-7770 x247 mbush@cardiacassist.com
CardiacAssist, Inc.CONTACT: Jennifer Hanson, of Armada Medical Marketing, +1-303-623-1190,Ext. 239, or jenniferh@armadamedical.com; or Monica Bush, of CardiacAssist,Inc., +1-412-963-7770, Ext. 247, or mbush@cardiacassist.com
Web site: http://www.cardiacassist.com//
